Market News (Page 1) - TendieTensor

Market News Page 1 of 218 • 5,436 articles

INSP FINAL DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP

GlobeNewswire Inc. • Rosen Law Firm

INSP FINAL DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP

12/19/2025 02:58 PM • Rosen Law Firm is reminding investors in Inspire Medical Systems, Synopsys, and CarMax of upcoming lead plaintiff deadlines in securities class action lawsuits. The cases allege misrepresentations regarding product demand and market conditions, with investors potentially eligible for compensation through contingency fee arrangements.

BACpO - Maintains Buy rating and sees promising growth potential for Medtronic's medical technologies
INSP - Company is subject to securities class action lawsuit alleging misrepresentation of market demand for Inspire V sleep apnea device and failure to disclose actual launch readiness, resulting in investor damages.

#securities class action #lead plaintiff deadline #investor compensation #misrepresentation #product launch

Third-Party Recognition Underscores Genesis Healthcare’s Ongoing Commitment to Excellence in Skilled Nursing Care

GlobeNewswire Inc. • Na

Third-Party Recognition Underscores Genesis Healthcare’s Ongoing Commitment to Excellence in Skilled Nursing Care

12/19/2025 02:55 PM • Genesis Healthcare announced that multiple affiliated skilled nursing facilities earned national recognition from U.S. News & World Report and Newsweek for 2026. Eleven Genesis-affiliated facilities were recognized by U.S. News & World Report as Best Nursing Homes, while four centers were named to Newsweek's America's Best Nursing Homes list. The recognitions are based on evaluations of clinical outcomes, staffing, patient experience, safety measures, and quality indicators.

BACpP - Maintains Buy rating and sees promising growth potential for Medtronic's medical technologies
GENNQ - The company received multiple prestigious third-party recognitions from U.S. News & World Report and Newsweek for 2026, with 11 and 4 facilities respectively earning Best Nursing Homes designations. These independent validations of quality care, clinical outcomes, and operational excellence demonstrate strong performance and commitment to patient care standards.

#skilled nursing facilities #national recognition #quality care #operational excellence #clinical outcomes #patient experience #long-term care #short-term rehabilitation

DP World Welcomes New Gemini AL3 Service in Saint John, Expanding Transatlantic Trade Connectivity

GlobeNewswire Inc. • Dp World

DP World Welcomes New Gemini AL3 Service in Saint John, Expanding Transatlantic Trade Connectivity

12/19/2025 02:45 PM • DP World announced that the Gemini Cooperation's westbound AL3 container service will begin operations at Port Saint John in January 2026, providing direct import connectivity from Southampton, UK. The service complements the existing eastbound AL1 service, creating a dedicated transatlantic 'Powerlane' with sailing times of 9-10 days from Hamburg to Saint John, enhancing access to Canadian and U.S. Midwest markets through DP World's Express Rail Service partnership with CPKC.

BACpQ - Maintains Buy rating and sees promising growth potential for Medtronic's medical technologies
CP - CPKC benefits from increased cargo volumes through its partnership with DP World's Express Rail Service, providing enhanced connectivity for inland North American markets through the new AL3 service.

#container shipping #transatlantic service #Port Saint John #import/export connectivity #rail logistics #Atlantic gateway

SNPS FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Synopsys, Inc. Investors to Secure Counsel Before Important December 30 Deadline in Securities Class Action - SNPS

GlobeNewswire Inc. • Rosen Law Firm

SNPS FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Synopsys, Inc. Investors to Secure Counsel Before Important December 30 Deadline in Securities Class Action - SNPS

12/19/2025 02:43 PM • Rosen Law Firm is reminding Synopsys investors of the December 30, 2025 deadline to join a securities class action lawsuit. The lawsuit alleges that Synopsys made materially false statements and failed to disclose that its increased focus on AI customers was deteriorating the economics of its Design IP business, negatively impacting financial results.

BACpS - Maintains Buy rating and sees promising growth potential for Medtronic's medical technologies
SNPS - The company is the subject of a securities class action lawsuit alleging material misstatements and non-disclosure of adverse business impacts related to AI customer focus deteriorating Design IP economics, resulting in investor damages.

#securities class action #lead plaintiff deadline #material misstatement #AI customers #Design IP business #investor compensation

CARMAX IMPORTANT DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages CarMax, Inc. Investors to Secure Counsel Before Important January 2 Deadline in Securities Class Action First Filed by the Firm – KMX

GlobeNewswire Inc. • Rosen Law Firm

CARMAX IMPORTANT DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages CarMax, Inc. Investors to Secure Counsel Before Important January 2 Deadline in Securities Class Action First Filed by the Firm – KMX

12/19/2025 02:41 PM • Rosen Law Firm has filed a securities class action lawsuit against CarMax, Inc. for allegedly making materially false and misleading statements about growth prospects during the Class Period (June 20 - November 5, 2025). The lawsuit claims defendants recklessly overstated growth that was primarily driven by temporary tariff-related speculation rather than sustainable business fundamentals. Investors who purchased CarMax securities during this period may be eligible for compensation. The lead plaintiff deadline is January 2, 2026.

BMLpG - Maintains Buy rating and sees promising growth potential for Medtronic's medical technologies
KMX - CarMax is the defendant in a securities class action lawsuit alleging material misstatements and misleading disclosures about growth prospects. The company allegedly overstated growth driven by temporary tariff-related customer speculation, indicating potential fraud and resulting investor damages.

#securities class action #CarMax #misleading statements #growth prospects #tariff speculation #investor compensation #lead plaintiff deadline

Class Action Reminder for SFM Investors: Kessler Topaz Meltzer & Check, LLP Reminds Sprouts Farmers Market, Inc. (SFM) Investors of Securities Fraud Class Action Lawsuit

GlobeNewswire Inc. • Kessler Topaz Meltzer & Check, Llp

Class Action Reminder for SFM Investors: Kessler Topaz Meltzer & Check, LLP Reminds Sprouts Farmers Market, Inc. (SFM) Investors of Securities Fraud Class Action Lawsuit

12/19/2025 01:37 PM • A securities class action lawsuit has been filed against Sprouts Farmers Market, Inc. for allegedly making false and misleading statements about growth and stability. The complaint alleges the company overstated consumer resilience and growth projections while failing to disclose macroeconomic pressures. The lead plaintiff deadline is January 26, 2026.

BACpM - Maintains Buy rating and sees promising growth potential for Medtronic's medical technologies
SFM - The company is accused of making false and misleading statements about business growth and stability, overstating consumer resilience, and failing to meet growth projections. These allegations of securities fraud and material misrepresentations directly harm investor confidence and indicate serious operational and disclosure failures.

#securities fraud #class action lawsuit #false statements #growth projections #macroeconomic pressures #lead plaintiff deadline

Nvidia Stock Climbs On Reports of US Review Of H200 Exports To China

Benzinga • Evette Mitkov

Nvidia Stock Climbs On Reports of US Review Of H200 Exports To China

12/19/2025 01:34 PM • Nvidia shares rose 2.95% on Friday following reports that the Trump administration has begun a formal review of H200 AI chip exports to China. The U.S. Commerce Department forwarded license applications to State, Energy, and Defense Departments for a 30-day review, with President Trump having final authority. Trump previously signaled willingness to allow H200 sales to China with a 25% government fee, arguing it could help U.S. chipmakers maintain competitive advantage. Multiple analysts maintain bullish ratings on Nvidia with increased price targets.

BACpN - Maintains Buy rating and sees promising growth potential for Medtronic's medical technologies
NVDA - Stock price increased 2.95% on news of formal export review process for H200 chips to China. Potential approval could open significant new market opportunities. All five recent analyst ratings are bullish with increased price targets, with Tigress Financial raising target to $350 and Truist Securities to $275.

#H200 exports #China trade #AI chips #export review #Trump administration #semiconductor #geopolitical

Brighty Launches Cashback Service for Crypto Cards, Offering Up to 1.75% Back

GlobeNewswire Inc. • Not Specified

Brighty Launches Cashback Service for Crypto Cards, Offering Up to 1.75% Back

12/19/2025 01:00 PM • Brighty, a Lithuanian crypto-native digital finance platform, has launched a cashback program for VISA and MasterCard cards offering rewards across all user tiers without requiring platform token purchases. The program features tiered cashback rates (0.5%-1.75%) with bonus category unlocks based on spending, and is currently running a 2x multiplier promotion through January 18, 2026.

BACpE - Maintains Buy rating and sees promising growth potential for Medtronic's medical technologies
V - Visa is mentioned only as a payment card partner integrated into Brighty's platform. There is no specific information about Visa's performance, strategy, or impact from this partnership.

#cashback program #digital nomads #crypto finance #VISA/MasterCard #European IBAN #stablecoin yields #blockchain technology

Meridianbet (GMGI) Sponsors Top European MMA Championship

GlobeNewswire Inc. • Na

Meridianbet (GMGI) Sponsors Top European MMA Championship

12/19/2025 12:49 PM • Meridianbet, a subsidiary of Golden Matrix Group, announced its title sponsorship of Fight Nation Championship (FNC 26) in Montenegro on December 20, 2025. The sponsorship leverages FNC's position as Europe's leading MMA promotion with 43 events and 272+ professional matches, serving as a talent pipeline for top-tier organizations. Meridianbet plans to integrate original programming and fighter partnerships to expand its sports media presence across its 18 operational jurisdictions.

BACpK - Maintains Buy rating and sees promising growth potential for Medtronic's medical technologies
GMGI - Strategic sponsorship deal demonstrates expansion of Meridianbet's sports media platform across established markets (Serbia, Montenegro, Bosnia-Herzegovina) and positions the company as an integrated media operator beyond traditional betting, leveraging a $1.5B global MMA market opportunity.

#sports betting #MMA sponsorship #Fight Nation Championship #content strategy #regional expansion #sports media #fighter partnerships

Evaxion Seeks New Partner For Gonorrhea Vaccine After Merck Opts Out

Benzinga • Vandana Singh

Evaxion Seeks New Partner For Gonorrhea Vaccine After Merck Opts Out

12/19/2025 12:43 PM • Merck & Co. has decided not to exercise its option for Evaxion's gonorrhea vaccine candidate EVX-B2 (protein-based version), allowing Evaxion to retain global rights and seek alternative licensing partners. The decision does not impact Evaxion's cash runway extending to mid-2027. Evaxion continues developing an mRNA version with Afrigen Biologics and previously out-licensed EVX-B3 to Merck in September for $7.5 million upfront plus up to $592 million in milestone payments.

BACpL - Maintains Buy rating and sees promising growth potential for Medtronic's medical technologies
EVAX - Merck's decision to opt out of the EVX-B2 protein-based vaccine represents a setback, requiring Evaxion to find a new partner. Stock declined 14.61% on the news. However, the company maintains cash runway and retains global rights to the candidate, providing some mitigation.

#gonorrhea vaccine #EVX-B2 #licensing partnership #biotech #vaccine development #mRNA vaccine #drug development

Umicore - Transparency notification by Bank of America Corporation

GlobeNewswire Inc. • Na

Umicore - Transparency notification by Bank of America Corporation

12/19/2025 12:30 PM • Bank of America Corporation, through its subsidiary Merrill Lynch International, has notified Umicore that it crossed below the 3% voting rights threshold on December 15, 2025. The holding now stands at 2.96% (0.29% direct voting rights and 2.67% equivalent financial instruments), down from the previous 3% threshold.

MU - Lost about 3.5% amid tech sector weakness
BAC - The notification reflects a routine reduction in holdings below a regulatory threshold. This is a standard disclosure event with no indication of strategic significance or market concern. The disposal appears to be a normal portfolio adjustment rather than a distress sale or major strategic shift.

#major holdings disclosure #voting rights threshold #Merrill Lynch International #share disposal #regulatory notification

Umicore - Transparantieverklaring van Bank of America Corporation

GlobeNewswire Inc. • Na

Umicore - Transparantieverklaring van Bank of America Corporation

12/19/2025 12:30 PM • Bank of America Corporation, through its subsidiary Merrill Lynch International, has exceeded the statutory 3% threshold of direct voting rights and equivalent financial instruments in Umicore as of December 15, 2025. The total holding amounts to 3.42%, comprising 0.29% direct voting rights and 2.67% equivalent financial instruments. The notification was filed on December 17, 2025, in accordance with Belgian disclosure regulations.

DXCM - Stock increased 6.7%, one of the top gainers in S&P 500
BAC - The notification is a routine regulatory disclosure of a shareholding threshold breach. There is no indication of strategic intent, hostile action, or material business impact. It is a factual reporting requirement with no inherent positive or negative implications for either party.

#shareholding disclosure #voting rights #financial instruments #regulatory notification #major holdings #threshold breach

Umicore - Déclaration de transparence par Bank of America Corporation

GlobeNewswire Inc. • Na

Umicore - Déclaration de transparence par Bank of America Corporation

12/19/2025 12:30 PM • Bank of America Corporation, through its subsidiary Merrill Lynch International, notified Umicore on December 17, 2025, that it crossed below the 3% legal threshold of voting rights and equivalent financial instruments on December 15, 2025. The total holding decreased to 2.96% (0.29% direct voting rights and 2.67% equivalent financial instruments), down from the previous 3.42% threshold.

CRWV - Tumbled 13% after trimming full-year revenue outlook
BAC - The notification reflects a routine regulatory disclosure of a downward threshold crossing in shareholding. This is a standard corporate action with no indication of positive or negative business implications. The decrease in holdings is a factual event requiring disclosure under transparency regulations.

#voting rights disclosure #shareholding notification #threshold crossing #financial instruments #transparency regulation

GlobeNewswire Inc. • Na

Transaction in Own Shares

12/19/2025 12:29 PM • Shell plc repurchased 1,967,666 shares on 19 December 2025 across multiple trading venues (LSEG and XAMS) at prices ranging from 26.58 to 30.90 GBP/EUR per share. The purchases are part of the company's existing share buyback programme authorized through 30 January 2026, with Merrill Lynch International managing trading decisions independently.

SHEL - Share buyback announcements are typically neutral signals. While buybacks can indicate management confidence in valuation and provide shareholder returns, they represent a routine capital allocation decision rather than material business news. The transaction is procedural in nature and conducted within pre-authorized parameters.

#share buyback #share repurchase #own shares #capital allocation #market regulation compliance #LSEG #XAMS

DEADLINE ALERT for DEFT, OWL, and BTDE: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

GlobeNewswire Inc. • The Law Offices Of Frank R. Cruz

DEADLINE ALERT for DEFT, OWL, and BTDE: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

12/19/2025 12:19 PM • Class action lawsuits have been filed against DeFi Technologies Inc. (DEFT), Blue Owl Capital Inc. (OWL), and Bitdeer Technologies Group (BTDR) for allegedly making materially false and misleading statements. DEFT faces allegations of undisclosed delays in its DeFi arbitrage strategy and overstated competition impact. OWL is accused of failing to disclose liquidity issues from BDC redemptions. BTDR allegedly misrepresented the readiness of its SEAL04 chip for mass production. Investors have until January 30, 2026 (DEFT) and February 2, 2026 (OWL and BTDR) to file lead plaintiff motions.

DEFT - Class action alleges material misstatements regarding delayed DeFi arbitrage strategy execution, understated competitive pressures, and failure to meet revenue guidance, indicating serious operational and disclosure issues.

#class action lawsuit #securities fraud #shareholder litigation #material misstatement #disclosure failure #investor losses

Reddit: Why Is It the New Growth Stock to Beat?

Investing.com • Nathan Reiff

Reddit: Why Is It the New Growth Stock to Beat?

12/19/2025 12:16 PM • Reddit has emerged as a standout growth stock in 2025, returning 37% year-to-date while competitors like Meta and Pinterest underperformed. The platform's strength is driven by impressive user engagement (116 million daily active users, up 20% YOY), surging revenue ($585 million, up 67% YOY), and international expansion. With ARPU at $5.04 (up 41% YOY) still significantly below competitors, Reddit has substantial room for monetization improvement. Analysts remain optimistic with 18 of 29 assigning Buy ratings, though the stock is nearing consensus price targets.

RDDT - Strong 37% YOY return, impressive 20% user growth to 116M DAU, 67% revenue growth to $585M, 400% EPS growth, and 31% international user growth. Significant ARPU upside potential ($5.04 vs Meta's ~$15) and analyst support (18 of 29 Buy ratings) indicate strong growth trajectory.

#user engagement #revenue growth #ARPU monetization #international expansion #AI opportunity #advertising momentum #daily active users

Morgan & Morgan Announces Record-Breaking Year Of Awards

GlobeNewswire Inc. • Not Specified

Morgan & Morgan Announces Record-Breaking Year Of Awards

12/19/2025 12:16 PM • Morgan & Morgan, America's largest injury law firm, announced it received hundreds of honors from leading legal publications in 2025, including recognition as the best Civil Rights/Discrimination firm by The National Law Journal's Elite Trial Lawyers. Over 240 firm attorneys were recognized by Super Lawyers, and the firm highlighted major achievements including a $425.7 million verdict against Google in a data privacy case.

GOOG - Google was ordered to pay $425.7 million in a data privacy verdict for surreptitiously collecting users' data without permission, representing a significant legal loss and potential reputational damage related to privacy practices.

#Morgan & Morgan #legal awards #injury law firm #data privacy litigation #Google verdict #attorney recognition #civil rights #mass torts

Sony Goes All-In On Snoopy, Scoops Up Control Of Peanuts Empire

Benzinga • Nabaparna Bhattacharya

Sony Goes All-In On Snoopy, Scoops Up Control Of Peanuts Empire

12/19/2025 12:10 PM • Sony Group has announced plans to acquire WildBrain's 41% stake in Peanuts Holdings for C$630 million ($457.40 million), increasing Sony's ownership to approximately 80% while the Schulz family retains 20%. The deal, subject to regulatory approval, positions Sony to leverage its global network to expand the iconic Peanuts franchise. Sony shares declined 1.43% following the announcement.

SONY - While the acquisition represents a strategic expansion of Sony's Peanuts portfolio and demonstrates confidence in the franchise's long-term value, the stock declined 1.43% on the announcement. The market's negative reaction suggests investors may view the C$630 million investment as costly or have concerns about execution, offsetting the positive strategic rationale.

#Sony #Peanuts #WildBrain #acquisition #controlling interest #franchise expansion #M&A

3 REITs to Watch as Fed Rate Cut Bets Heat Up for 2026

Investing.com • Jesse Cohen

3 REITs to Watch as Fed Rate Cut Bets Heat Up for 2026

12/19/2025 12:10 PM • As Federal Reserve rate cut expectations build for 2026, Real Estate Investment Trusts (REITs) are positioned to benefit from lower borrowing costs and increased property valuations. Three REITs stand out: Realty Income, known for monthly dividends and defensive tenants; Prologis, the world's largest industrial logistics REIT; and Digital Realty Trust, a hyperscale data center leader benefiting from AI growth.

PFE - Acquiring company with proposed merger, but no explicit positive or negative indicators in the article
O - Strong defensive income play with 32-year dividend streak, 5.93% yield, 11.6% analyst upside target, stable Buy consensus, and recession-resistant tenants. Benefits from lower rates and European expansion opportunities.

#REITs #Federal Reserve #rate cuts #2026 #dividend yield #industrial logistics #data centers #monetary policy

Rocket Lab’s Sharp Rebound: What’s Behind the Recent Momentum

Investing.com • Ryan Hasson

Rocket Lab’s Sharp Rebound: What’s Behind the Recent Momentum

12/19/2025 12:05 PM • Rocket Lab (RKLB) has rebounded nearly 30% after a 50% pullback, driven by SpaceX IPO speculation valuing the competitor at $1.5 trillion, renewed sector enthusiasm, and strong operational execution including successful JAXA and U.S. Space Force missions. The company's upcoming Neutron rocket launch in H1 2026 represents a major catalyst that could significantly expand its addressable market and revenue profile.

RKLB - Stock has delivered 111% YTD returns and 1,200% three-year gains. Recent recovery driven by successful mission execution (JAXA and U.S. Space Force contracts completed ahead of schedule), sector-wide enthusiasm from SpaceX IPO speculation, and upcoming Neutron rocket launch in H1 2026 that could dramatically expand the company's market opportunity and competitive positioning.

#Rocket Lab #space industry #SpaceX IPO #Neutron rocket #small-lift launch services #mission success #sector momentum

Could Micron Be 2026’s Breakout AI Stock?

Investing.com • Shane Neagle

Could Micron Be 2026’s Breakout AI Stock?

12/19/2025 12:05 PM • Micron Technology delivered exceptional fiscal Q1 2026 results with $13.64B revenue (57% YoY growth) and $4.78 EPS, beating expectations. The company forecasts Q2 revenue of $18.3-19.1B and projects adjusted EPS of $8.22-8.62, far exceeding analyst estimates. As one of only three companies capable of manufacturing high-bandwidth memory (HBM) chips for AI processors, Micron has sold out its entire 2026 HBM supply. Morgan Stanley ranks Micron's upside second only to Nvidia in the AI space, positioning it as a potential 2026 breakout stock.

MU - Exceptional earnings beat with 57% YoY revenue growth, record operating cash flow, aggressive forward guidance significantly exceeding consensus, sold-out HBM supply through 2026, and positioned as critical AI infrastructure player with immediate profitability scaling.

#AI infrastructure #high-bandwidth memory (HBM) #data center #memory chips #AI supercycle #fiscal 2026 guidance #supply constraints

Why SuperX AI Technology Stock Was Wilting This Week

The Motley Fool • Eric Volkman

Why SuperX AI Technology Stock Was Wilting This Week

12/19/2025 12:01 PM • SuperX AI Technology announced a $23.4 million capital raise through the sale of 1.8 million units (shares and warrants) to institutional investors, causing the stock to decline 25% week-to-date. The company plans to use proceeds for AI server production, R&D, and general corporate purposes. The announcement triggered investor concerns about share dilution and financial stability, particularly as the broader market pulls back from AI stocks amid valuation concerns.

BAC - Maintains Buy rating and sees promising growth potential for Medtronic's medical technologies
SUPX - Stock declined 25% week-to-date following the capital raise announcement. Investors reacted negatively to concerns about share dilution and the company's financial situation. The analyst noted the company lacks consistent bottom-line profits and recommended avoiding the stock despite its appealing business profile as an AI infrastructure specialist.

#capital raise #share dilution #AI infrastructure #institutional investors #private placement #AI servers #stock decline #valuation concerns

Up 50% in 2025, Should You Buy ASML Stock Right Now?

The Motley Fool • Leo Sun

Up 50% in 2025, Should You Buy ASML Stock Right Now?

12/19/2025 12:01 PM • ASML, the world's only producer of extreme ultraviolet (EUV) lithography systems, has surged 50% in 2025 and reached record highs. While the company benefits from AI and cloud market expansion, it faces headwinds from Chinese export restrictions and slowing 2026 growth projections. Despite a premium valuation of 34x forward earnings, analysts view it as a worthwhile long-term investment due to its monopolistic position and significant pricing power in the semiconductor equipment market.

BACpB - Maintains Buy rating and sees promising growth potential for Medtronic's medical technologies
ASML - ASML maintains a monopoly on crucial EUV lithography technology, benefits from AI and cloud market growth, and has strong pricing power. Despite near-term headwinds from China restrictions and slowing 2026 growth, the company is positioned well for long-term semiconductor market expansion with revenue expected to reach €44-60 billion by 2030.

#ASML #semiconductor equipment #EUV lithography #AI market expansion #China export restrictions #valuation #long-term investment

eXp Realty Elevates Agent Tech-Stack with Land id Collaboration, Bringing Market-Leading Property Mapping and Intelligence to Agents Nationwide

GlobeNewswire Inc. • Not Specified

eXp Realty Elevates Agent Tech-Stack with Land id Collaboration, Bringing Market-Leading Property Mapping and Intelligence to Agents Nationwide

12/18/2025 12:00 PM • eXp Realty partners with Land id to provide agents nationwide with advanced property mapping and geospatial data intelligence, enhancing their technological capabilities across residential and specialized real estate markets.

OXY.WS - Rose 2.5% after beating third-quarter earnings expectations
EXPI - Proactively expanding technological capabilities, strengthening agent support, and improving market competitiveness through strategic partnership

#real estate #technology #mapping #geospatial data #property intelligence

WORLDLINE : EGM - Availability of preparatory documents

GlobeNewswire Inc. • Worldline

WORLDLINE : EGM - Availability of preparatory documents

12/18/2025 12:00 PM • Worldline has called an Extraordinary General Meeting on January 8, 2026, at 10:00 a.m. in Paris. The meeting will be broadcast live on the company's website and preparatory documents are available online.

OXY - Rose 2.5% after beating third-quarter earnings expectations
WRDLY - The article is a standard corporate announcement about an upcoming general meeting, presenting factual information without indicating positive or negative business performance

#Extraordinary General Meeting #shareholders #corporate governance #investor relations